Constipation is a common complication in cancer patients, with an incidence rate ranging from 30% to 90%. It is particularly prevalent among those using opioids and patients with advanced cancer. Currently, standardized screening and assessment systems for constipation in community-dwelling cancer patients are lacking. Unmanaged constipation may lead to severe complications such as bowel obstruction and malnutrition, significantly impacting patients' quality of life. Chinese Expert Consensus on Constipation Screening and Assessment for Community Cancer Patients (2025 Edition) developed by the Community Rehabilitation Working Committee of Chinese Rehabilitation Medicine Association with a multidisciplinary expert panel, addresses 8 core issues: definition of constipation, risk factors, screening/assessment tools, management for special populations, and referral indications. Based on relevant literature, 12 recommendations are proposed. The consensus aims to establish evidence-based standardized assessment tools, integrate risk evaluation, self-monitoring, and referral strategies, and guide community healthcare providers in early identification of high-risk patients while optimizing screening and assessment protocols.

肿瘤患者便秘是临床常见的并发症，发生率高达30%~90%，尤其在使用阿片类药物及晚期癌症患者中更常见。目前针对社区肿瘤患者便秘筛查与评估体系缺乏规范，未经管理的便秘可能导致肠梗阻、营养不良等严重并发症，影响患者的生活质量。《社区肿瘤患者便秘筛查与评估的中国专家共识（2025年版）》由中国康复医学会社区康复工作委员会联合多学科专家组制定，总结了涵盖便秘定义、风险因素、筛查评估工具、特殊人群管理及转诊指征等8个核心问题，结合相关文献共提出12条推荐意见。旨在通过循证方法构建规范化评估工具，整合风险评估、自我监测及转诊策略，指导社区医护人员早期识别高危患者，优化筛查与评估流程。